Cartesian Growth Corporation III Class A Ordinary Shares Total Liabilities
Cartesian Growth Corporation III Class A Ordinary Shares total liabilities. Based on the latest financial reports, Cartesian Growth Corporation III Class A Ordinary Shares (CGCT) has total liabilities worth $13.54 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See CGCT working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Total Liabilities of Cartesian Growth Corporation III Class A Ordinary Shares (2024–2024)
Total liabilities of Cartesian Growth Corporation III Class A Ordinary Shares from 2024 to 2024. This chart illustrates how Cartesian Growth Corporation III Class A Ordinary Shares's total liabilities have evolved over time, based on quarterly financial data.
Cartesian Growth Corporation III Class A Ordinary Shares Competitors by Total Liabilities
The table below lists competitors of Cartesian Growth Corporation III Class A Ordinary Shares ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hefei Kewell Power System Co Ltd
SHG:688551
|
China | CN¥408.18 Million |
|
Advanced Enzyme Technologies Limited
NSE:ADVENZYMES
|
India | Rs-16.83 Billion |
|
Hangzhou Yitong New Material Co. LTD
SHE:300930
|
China | CN¥773.08 Million |
|
MCNEX Co. Ltd
KQ:097520
|
Korea | ₩221.01 Billion |
|
Sidetrade
PA:ALBFR
|
France | €45.89 Million |
|
Vodafone Group PLC
LSE:VOD
|
UK | GBX75.52 Billion |
|
Hoasen Group
VN:HSG
|
Vietnam | ₫10.34 Trillion |
|
FocalTech Systems Co Ltd
TW:3545
|
Taiwan | NT$4.92 Billion |
Liability Composition Analysis (2024–2024)
This chart breaks down Cartesian Growth Corporation III Class A Ordinary Shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Cartesian Growth Corporation III Class A (CGCT) total assets.
Liquidity & Leverage Metrics
Cartesian Growth Corporation III Class A Ordinary Shares Total Liabilities Ratios Explained
Cartesian Growth Corporation III Class A Ordinary Shares total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.08 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.05 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.05 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cartesian Growth Corporation III Class A Ordinary Shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cartesian Growth Corporation III Class A Ordinary Shares (2024–2024)
The table below shows the annual total liabilities of Cartesian Growth Corporation III Class A Ordinary Shares from 2024 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $284.50K | -- |
About Cartesian Growth Corporation III Class A Ordinary Shares
Cartesian Growth Corporation III focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2024 and is based in New York, New York.